Doctor profile · Federal record

Dr. Nadia Urato, M.D.

Mohs-Micrographic Surgery Physician (CMS: Dermatology) · Dermatology Physician · Mohs-Micrographic Surgery Physician · Sarasota, FL

  • NPI 1841289519
  • Accepts Medicare
  • 29 yrs in practice
  • Licensed in 2 states
  • Female
  • Solo practice
  • No sanctions

Practice & contact

Operates at 2 locations .

NPPES Updated May 11, 2026
Primary practice
3231 Gulf Gate Dr Ste 105
Sarasota, FL 342312406
(941) 263-8866
fax (941) 263-8886
Additional location
761 Worcester RD Ste 331
Framingham, MA 017015224
(508) 644-0040
fax (508) 449-0079
Mailing address
6211 Singletree Trl
Sarasota, FL 342418585

Credentials & registration

NPPES · NUCC
NPI registered
October 2005 — 21 yrs on file
Profile last updated
June 3, 2024
Year of graduation
1997 — 29 yrs since
Specialty taxonomy
207ND0101X — NUCC code
State licenses (3)
Florida #ME 85461 · Florida #ME85461 · Massachusetts #204298
Medicaid
FL #110916400

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1841289519. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
28,629
Distinct HCPCS
10
Medicare allowed
$319,448
HCPCS Description Services Patients Avg allowed
J7345 Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg 26,000 61 $2
17003 Destruction of precancer skin growth, 2-14 growths 604 123 $6
11102 Biopsy of related skin growth, first growth 279 219 $91
99213 Established patient office or other outpatient visit, 20-29 minutes 247 154 $88
96922 Treatment of inflammatory skin disease using laser, more than 500.0 sq cm 192 20 $222
11103 Biopsy of related skin growth, each additional growth 179 105 $49
17000 Destruction of precancer skin growth, 1 growth 172 132 $43
99203 New patient office or other outpatient visit, 30-44 minutes 142 142 $110
96921 Treatment of inflammatory skin disease using laser, 250.0-500.0 sq cm 120 19 $164
96567 Application of light to destroy precancer skin growth 86 42 $134

In context: peer comparison

Among 2 peers in this city , average services per provider: 591. This provider delivers 48× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$685
Transactions
30
Manufacturers
14
Payer (manufacturer) Industry Txns Amount
Incyte Corporation 5 $135.47
Organogenesis Inc. 2 $87.22
Boehringer Ingelheim Pharmaceuticals, Inc. 3 $75.27
Novartis Pharmaceuticals Corporation 2 $64.56
E.R. Squibb & Sons, L.L.C. 2 $49.16
Arcutis Biotherapeutics, Inc. 3 $47.99
Galderma Laboratories, L.P. 3 $43.57
Janssen Biotech, Inc. 2 $38.24
Amgen Inc. 2 $33.72
Biofrontera Inc. 2 $28.27
GENZYME CORPORATION 1 $23.89
STRATA Skin Sciences, Inc. 1 $22.19
PFIZER INC. 1 $19.74
Journey Medical Corporation 1 $16.05

By nature of payment

Food and Beverage
$685

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
588
Patients
428
Total drug cost
$9,779
Drug Type Claims Patients Total cost
Triamcinolone Acetonide Generic 139 106 $1,566
Mupirocin Generic 123 97 $1,015
Cephalexin Generic 108 87 $756
Ketoconazole Generic 99 55 $1,884
Hydrocortisone Generic 58 49 $805
Clobetasol Propionate Generic 48 34 $3,167
Doxycycline Hyclate Generic 13 0 $586

Frequently asked questions

Auto-generated from federal data
What is Dr. Nadia Urato's medical specialty?
Dr. Nadia Urato practices Mohs-Micrographic Surgery Physician in Sarasota, FL.
Where does Dr. Nadia Urato practice?
Dr. Nadia Urato practices at 3231 Gulf Gate Dr Ste 105, Sarasota, FL 342312406. Office phone: 9412638866.
What is Dr. Nadia Urato's NPI?
Dr. Nadia Urato's National Provider Identifier (NPI) is 1841289519, issued by NPPES.
Does Dr. Nadia Urato accept Medicare assignment?
Yes. Dr. Nadia Urato accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Nadia Urato commonly perform?
Top Medicare-reported procedures in 2023: Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg (HCPCS J7345); Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Biopsy of related skin growth, first growth (HCPCS 11102). Source: CMS Medicare Physician & Other Practitioners file.